This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly an earth-shattering moment in pancreatic cancer.” Daraxonrasib, an ...

When former Nebraska Sen. Ben Sasse was diagnosed with Stage 4 pancreatic cancer in December, he was given three to four months to live. Now a drug by Revolution Medicines is giving him precious more ...

Pancreatic cancer is one of the most challenging diseases to treat, and while survival rates have improved since the 1970s, they have plateaued in recent years. But two promising drugs in the pipeline ...

Pancreatic cancer is one of the deadliest cancers. It killed nearly 52,000 Americans last year, many within a year of diagnosis. Now, there are some new experimental medicines with the potential to ...

SAN DIEGO — Experimental therapies with radically different approaches are stirring a wave of optimism that survival rates could substantially improve for pancreatic cancer, one of the most stubbornly ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

In separate clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology. By Rebecca Robbins and Gina Kolata Two treatments being tested ...

Donna Gustafson had a harder time than usual shaking off the jet lag from her 22-hour journey from Florida to Australia. Two days into her trip, her skin took on the yellow hue of jaundice. Subscribe ...

A new drug is offering hope and time for patients and their families and doubling the survival rate for one of the most deadly cancers. Donna Husar is grateful for the extra time. In 2020, her husband ...